Results for Childhood Brain Tumors

Dr. Minturn's primary clinical and research focus is the development of early-phase clinical trials targeting the molecular drivers of brain/spinal cord tumors. She also focuses on late effects of tumor-directed therapies on the developing nervous system and neurocognitive effects of treatment.

Dr. Resnick's research focuses on the cell signaling mechanisms of oncogenesis and tumor progression in brain tumors. He studies signaling cascades and alterations to elucidate the molecular and genetic underpinnings in order to develop targeted therapies. As co-director of the Center of Data-Driven Discovery in Biomedicine, he leads a multidisciplinary team building and supporting a scalable, patient-focused healthcare and educational discovery ecosystem.

Dr. Hocking’s research aims to better understand the neurodevelopmental consequences of having survived childhood cancer or having neurofibromatosis type 1, to identify those who are most at risk for poor outcomes, and to intervene in some way in order to improve quality of life.